CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. 2022

Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
Department of Cardiology, Fujita Health University School of Medicine, Aichi, Japan. yukio.ozaki7@gmail.com.

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072657 ST Elevation Myocardial Infarction A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION). ST Elevated Myocardial Infarction,ST Segment Elevation Myocardial Infarction,STEMI
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D054855 Drug-Eluting Stents Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu. Drug-Coated Stent,Drug-Coated Stents,Drug-Eluting Stent,Stents, Drug-Coated,Stents, Drug-Eluting,Drug Coated Stent,Drug Coated Stents,Drug Eluting Stent,Drug Eluting Stents,Stent, Drug-Coated,Stent, Drug-Eluting,Stents, Drug Coated,Stents, Drug Eluting
D062645 Percutaneous Coronary Intervention A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting. Percutaneous Coronary Revascularization,Coronary Intervention, Percutaneous,Coronary Interventions, Percutaneous,Coronary Revascularization, Percutaneous,Coronary Revascularizations, Percutaneous,Intervention, Percutaneous Coronary,Interventions, Percutaneous Coronary,Percutaneous Coronary Interventions,Percutaneous Coronary Revascularizations,Revascularization, Percutaneous Coronary,Revascularizations, Percutaneous Coronary
D032921 Consensus General agreement or collective opinion; the judgment arrived at by most of those concerned. Consensus Development,Development, Consensus

Related Publications

Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
April 2018, Cardiovascular intervention and therapeutics,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
April 2012, Expert review of cardiovascular therapy,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
April 2000, Laeknabladid,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
January 2024, Cardiovascular intervention and therapeutics,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
October 2020, Korean circulation journal,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
April 2021, Korean circulation journal,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
August 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
June 2014, Journal of the American College of Cardiology,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
June 2014, Circulation,
Yukio Ozaki, and Hironori Hara, and Yoshinobu Onuma, and Yuki Katagiri, and Tetsuya Amano, and Yoshio Kobayashi, and Takashi Muramatsu, and Hideki Ishii, and Ken Kozuma, and Nobuhiro Tanaka, and Hitoshi Matsuo, and Shiro Uemura, and Kazushige Kadota, and Yutaka Hikichi, and Kenichi Tsujita, and Junya Ako, and Yoshihisa Nakagawa, and Yoshihiro Morino, and Ichiro Hamanaka, and Nobuo Shiode, and Junya Shite, and Junko Honye, and Tetsuo Matsubara, and Kazuya Kawai, and Yasumi Igarashi, and Atsunori Okamura, and Takayuki Ogawa, and Yoshisato Shibata, and Takafumi Tsuji, and Junji Yajima, and Kaoru Iwabuchi, and Nobuo Komatsu, and Teruyasu Sugano, and Masaru Yamaki, and Shinichiro Yamada, and Hiroaki Hirase, and Yuusuke Miyashita, and Fuminobu Yoshimachi, and Masakazu Kobayashi, and Jiro Aoki, and Hirotaka Oda, and Yoshiaki Katahira, and Kinzo Ueda, and Masami Nishino, and Koichi Nakao, and Ichiro Michishita, and Takafumi Ueno, and Taku Inohara, and Shun Kohsaka, and Tevfik F Ismail, and Patrick W Serruys, and Masato Nakamura, and Hiroyoshi Yokoi, and Yuji Ikari, and
July 2007, The Medical clinics of North America,
Copied contents to your clipboard!